Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval to GSK's oral antibiotic pill, ...

Summary GSK's lawsuit against Moderna over lipid nanoparticle technology could severely impact Moderna's revenue from Spikevax and mResvia, and delay their breakeven point. The lawsuit adds ...

Rather than thinking in terms of single targets or isolated therapeutic classes, we now have the opportunity and imperative ...

In a post to its corporate LinkedIn page, Veeva (VEEV) offered congratulations to GSK‘s (GSK) SVP of global medical affairs and technology, Kieron Scrutton, on the successful Vault CRM go-live across ...

Pharma giant GSK and Elegen are partnering to leverage the California-based DNA manufacturer's proprietary technology to help develop new vaccines and medicines.

Pharmaceutical group GlaxoSmithKline Plc is said to be in discussions with chipmaker Qualcomm Inc to form a joint venture as GSK looks for ways to develop medical technology, Bloomberg reported on ...

SR One, a life sciences investment firm spun out of biotech giant GlaxoSmithKline, raised $600 million to close its second venture fund.

British drugmaker GSK is preparing for potential new U.S. tariffs on its medicines and can handle the challenge, the company’s leader said Wednesday. “I would say we’ve been preparing, we ...

is using emerging radio frequency identification (RFID) technology as part of a pilot program to crack down on drug counterfeiting and to protect consumers. GSK said Wednesday that bottles of its ...

GSK originally licensed the technology from the University of Pennsylvania. AskBio will have exclusive access to what it called "recombinant adeno-associated virus vector (rAAV) serotypes".